Results of a phase II trial with second-line cystemustine at 60 mg/m2 in advanced soft tissue sarcoma: A trial of the EORTC early clinical studies group

European Journal of Cancer

Volumn 34, Issue 3, 1998, Pages 422-423

  Cure H ^a   Krakowski, I ^b   Adenis, A ^c   Tubiana, N ^d   Kerbrat, P ^e   Roche H ^f   Chevallier, B ^g   Lentz, M A ^h   Fumoleau, P ⁱ   Chollet, P ^a  

^a CENTRE JEAN PERRIN   (France)

^b CENTRE ALEXIS VAUTRIN   (France)

^c CENTRE OSCAR LAMBRET   (France)

^d DUPUYTREN UNIVERSITY HOSPITAL   (France)

^e CENTRE EUGÈNE MARQUIS   (France)

^f INSTITUT CLAUDIUS REGAUD   (France)

^g CENTRE HENRI BECQUEREL   (France)

^h EORTC DATA CENTER   (Belgium)

ⁱ CENTRE RENÉ GAUDUCHEAU   (France)

Author keywords

Cystemustine; New nitrosourea; Soft tissue sarcoma

Indexed keywords

CYSTEMUSTINE; NITROSOUREA DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SOFT TISSUE SARCOMA; THROMBOCYTOPENIA; VOMITING;

EID: 0032006380     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00357-2     Document Type: Article

References (8)

1. 1. Rouessé J, Spielmann M. Soft tissue sarcomas of adults. In Droz JP, Cvitkovic E, Armand JP, Khoury S, eds. Handbook of Chemotherapy in Clinical Oncology. Paris, FIIS Publisher, RGP, 1988, 345.
2. 2. Cappelaere P, Chauvergne J, Armand JP. Sarcome des tissus mous de l'adulte. In Cappelaere P, Chauvergne J, Armand JP, eds. Manuel Pratique de Chimiothérapie Anticancéreuse. Paris, Springer-Verlag, 1992, 334.
3. 3. Tursz T, Verweij J, Judson I, et al. Is high-dose chemotherapy of interest in advanced soft tissue sarcoma? An EORTC randomized phase III trial. Proc Am Soc Clin Oncol 1996, 15, 337 (abstract 973).
4. 4. van Geel AN, Pastorino U, Jauch KW, et al. Surgical treatment of lung metastases. The European Organization for Research and Treatment of Cancer - Soft Tissue and Bone Sarcoma Group Study of 255 patients. Cancer 1996, 77, 675-682.
5. 5. Dombernowsky P, Mouridsen H, Nielsen OS, et al. A phase III study comparing adriamycin vs two schedules of high dose epirubicin in advanced soft tissue sarcoma. EORTC Soft Tissue & Bone Sarcoma Cooperative Group (STBSG). Proc Am Soc Clin Oncol 1995, 14, 237 (abstract 1688).
6. 6. Santoro A, Tursz T, Mouridsen H, et al. Doxorubicin versus Cyvadic versus Doxorubicin plus Ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1995, 13, 1537-1545.
7. 7. Van Oosterom At. The treatment of advanced soft tissue sarcomas. Rhône-Poulenc Rorer International Symposium on Taxotere, Prague (Czech Republic), January 27, 1996.
8. 8. Roché H, Adenis L, Curé H, et al. on behalf of the EORTC-ECSG. Phase II trial of cystemustine, a new nitrosourea, as second line treatment of malignant gliomas. European Society of Medical Oncology 21st Congress, Vienne (Austria), November 1-5, 1996.